Résultats de la recherche - 17 results

Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.

aim to provide updated global and regional pooled overall, type-specific, and age-specific prevalence estimates of genital HPV infection in men. METHODS: We conducted a systematic review and ...

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.

efficiency and PCR inhibition. 1300 VALGENT-2 study samples (from women aged 20-60 attending the Scottish cervical cancer screening program) were tested with the index assay and the GP5 +/6+ PCR enzyme ...

The European response to the WHO call cervical cancer as a public health problem

Issue 2 (2021) Keywords: cervical cancer screening COVID-19 elimination of cervical cancer Europe HPV vaccination WHO Abstract: The age‐standardised incidence of cervical cancer in Europe varies widely ...

Tackling cervical cancer in Europe amidst the COVID-19 pandemic.

least 90% of girls by age 15 years, by offering screening at least twice in a lifetime to 70% or more of the target age populations and treat more than 90% of women with screen-detected lesions. Recently, ...

The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer

the working age population (16–64 years). There is a strong need to assess and understand their reintegration on the labour market, which underlines and ensures their social integration and quality of ...

Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.

Volume 28, Issue 1 (2019) Keywords: Adult Early Detection of Cancer Female France Humans middle aged morbidity Papillomavirus Vaccines REGISTRIES Uterine Cervical Neoplasms Abstract: In 1994, a pilot ...

Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.

those associated with vaccine HPV types and any cervical precancer. Exposure groups were: women aged: 15-26 or 24-45 years being initially negative for high-risk HPV (hrHPV) or negative for the vaccine ...

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.

Uteri Early Detection of Cancer Female Genotype Genotyping Techniques Humans middle aged Papillomaviridae Papillomavirus Infections Reproducibility of Results Sensitivity and Specificity Slovenia Uterine ...

QR code

QR code for this page URL